{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:33:25Z","timestamp":1791232405955,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":3209,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jmoldx.2010.10.004","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T12:47:33Z","timestamp":1298724453000},"page":"180-188","source":"Crossref","is-referenced-by-count":193,"title":["Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay"],"prefix":"10.1016","volume":"13","author":[{"given":"Thomas","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Boe","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2010.10.004_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"54","year":"2008"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib3","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allerg Clin Immunol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","article-title":"Recent advances in the understanding of mastocytosis: the role of KIT mutations","volume":"138","author":"Orfao","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0145-2126(02)00272-2","article-title":"Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liver","volume":"27","author":"Ferrao","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20050807","article-title":"Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation","volume":"202","author":"Zappulla","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib8","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.4049\/jimmunol.180.8.5466","article-title":"Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens","volume":"180","author":"Mayerhofer","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOH.0b013e3283366c59","article-title":"Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature","volume":"17","author":"Pardanani","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib11","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","article-title":"Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms","volume":"22","author":"Zermati","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib13","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0609.2010.01407.x","article-title":"A critical reappraisal of treatment response criteria in systemic mastocytosis and a proposal for revisions","volume":"84","author":"Pardanani","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","article-title":"Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it","volume":"58B","author":"Escribano","year":"2004","journal-title":"Proposals of the Spanish network on mastocytosis (REMA) Cytom Part B Clin Cytom"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C","article-title":"Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats","volume":"45","author":"Roederer","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib17","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib18","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer Program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2402922","article-title":"Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects","volume":"17","author":"van der Velden","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib20","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.leu.2404680","article-title":"Quantitative profiling of codon 816 KIT mutations can aid in the classification of systemic mast cell disease","volume":"21","author":"Zhao","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","article-title":"Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis","volume":"113","author":"Fritsche-Polanz","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib23","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1373\/clinchem.2006.068205","article-title":"Sensitive detection of KIT D816V in patients with mastocytosis","volume":"52","author":"Tan","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jcp.2007.047928","article-title":"Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR","volume":"61","author":"Schumacher","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1746-1596-2-37","article-title":"Sensitive and reliable detection of Kit point mutation Asp 816 to Val in pathological material","volume":"2","author":"Kahler","year":"2007","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2353\/jmoldx.2006.060007","article-title":"JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility\u2014a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology","volume":"8","author":"Steensma","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"Hughes","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2353\/jmoldx.2006.060089","article-title":"Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia","volume":"8","author":"Corless","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00277-007-0430-3","article-title":"Mast cell leukemia: a report of ten cases","volume":"87","author":"Valentini","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12185-008-0166-4","article-title":"Advanced mast cell disease: an Italian Hematological Multicenter experience","volume":"88","author":"Pagano","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib31","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/path.2677","article-title":"Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)","volume":"220","author":"Sotlar","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1525-1578(10)60529-6","article-title":"Demonstration that mast cells. T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis","volume":"6","author":"Taylor","year":"2004","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2010.10.004_bib33","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2120::AID-CNCR10>3.0.CO;2-C","article-title":"Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis","volume":"83","author":"Worobec","year":"1998","journal-title":"Cancer"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T12:37:29Z","timestamp":1576240649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157810000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1525157810000590"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2010.10.004","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}